Market Place
Sourcing Support
Clinical Trial Shows Long-Term Efficacy Of Two Treatments
05 Oct 2025 //
PR NEWSWIRE
PTC Therapeutics Receives CRL for Vatiquinone NDA
20 Aug 2025 //
PRESS RELEASE
FDA Priority Review To PTC’s Vatiquinone For Friedreich’s Ataxia
19 Feb 2025 //
PR NEWSWIRE
PTC Therapeutics Submits Vatiquinone NDA for Friedreich Ataxia
19 Dec 2024 //
PR NEWSWIRE
PTC Therapeutics reports second trial flop for late-stage program
01 Jul 2023 //
ENDPTS
PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone
29 Jun 2023 //
PR NEWSWIRE
PTC Announces Initiation of Global Ph3 Trial to Evaluate Vatiquinone
30 Nov 2020 //
PRNEWSWIRE
PTC Announces Initiation of Global Ph 3 Trial to Evaluate Vatiquinone
30 Nov 2020 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.